Clinical updates, including trial initiations, enrollment status and data readouts and publications: ATCG, Delmar, Immutep, Lidds, Matinas, Molecular Templates, Palatin, Reneuron, Restorbio, Takeda, Terns, Zelira.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alnylam, Aravive, Axim, Azurrx, Bellerophon, Bioxcel, BMS, Eisai, Five Prime, Foamix, Mirati, Moleculin, Mustang, Ra, Recardio, Reneo, Sensorion.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acucela, Astellas, Celltrion Healthcare, Kubota, Noxopharm, Pfizer, Seattle Genetics, Takeda, TLC Co.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Atreca, Celltrion, Cytodyn, Genetx, Janssen, Noxopharm, Regulus, Sol-Gel, Takeda, Verona.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acucela, Advaxis, Annovis, Arcutis, Aveo, Ciclomed, Corvus, Hepion, Immunogenx, Innovation, Sanifit, Scynexis, Trovagene.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Mir Scientific, Predictive Laboratories, Puregraft, Trisalus Life Sciences.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abeona, Adamas, Allena, Antios, Freeline, Lilly, Longeveron, Merck, TLC.